Ocrelizumab (US) Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: Ocrevus

Top Sponsors

Washington University School of Medicine1
Northwestern University1

Indications

Multiple Sclerosis2
Multiple Sclerosis (MS) - Relapsing-remitting1
Weight Loss1

Chicago, Illinois1 trial

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Northwestern Memorial Hospital

St Louis, Missouri1 trial

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

Washington University School of Medicine in St. Louis

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.